Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients

Heliyon(2023)

Cited 0|Views6
No score
Abstract
Inhibition of the renin-angiotensin-aldosterone-system had no effect on the mortality of patients with COVID-19 and on their overall disease progression. However, it may be beneficial not to stop these medications as they decrease inflammation in the body and the levels of troponin, which are related to increased stress on the heart.
More
Translated text
Key words
SARS-CoV-2,Renin angiotensin aldosterone system,Cardiac biomarkers,Inflammatory biomarkers,Inflammation,Cytokines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined